alpha-beta integrin peptides (Integra)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namealpha-beta integrin peptides (Integra)
Drug Alias NameRGD-based angiogenesis antagonists (Integra)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsAngiogenesis disorderNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIntegra Lifesciences Holdings Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntegra Lifesciences Holdings Corp
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A